Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study (Q36678505)
Jump to navigation
Jump to search
scientific article published on 24 February 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study |
scientific article published on 24 February 2016 |
Statements
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study (English)
Miguel Martin
Jan C Brase
Amparo Ruiz
Aleix Prat
Ralf Kronenwett
Lourdes Calvo
Christoph Petry
Philip S Bernard
Manuel Ruiz-Borrego
Karsten E Weber
César A Rodriguez
Miguel A Segui
Maribel Casas
RosalÃa Caballero
Alvaro Rodriguez-Lescure
1 reference